The present disclosure relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR4 enzyme and are useful in the treatment of FGFR4-associated diseases such as cancer.

Edits on 30 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 30 Sep, 2023

Edits made to:

Infobox (+4 properties)

Infobox

Patent Inventor Names

Bo Shen0

Liang Lu0

Liangxing Wu0

Wenqing Yao0

Edits on 13 Jul, 2023

"Remove leading 0 from patent number"

Golden AI

edited on 13 Jul, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 09580423 Bicyclic heterocycles as FGFR4 inhibitors US Patent 9580423 Bicyclic heterocycles as FGFR4 inhibitors

Infobox

Patent Number

09580423

Patent Number

9580423

Edits on 25 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 25 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=09580423

Edits on 15 Jun, 2022

"Entity importer update"

Golden AI

edited on 15 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=09580423

Edits on 10 Jan, 2022

"Created via: Entity Importer"

Golden AI

created this topic on 10 Jan, 2022

Edits made to:

Infobox (+9 properties)

‌

US Patent 09580423 Bicyclic heterocycles as FGFR4 inhibitors

Infobox

Is a

Patent

Patent applicant

Incyte

Current assignee

Incyte

Patent jurisdiction

United States Patent and Trademark Office

Patent number

09580423

Date of patent

February 28, 2017

Patent application number

15047903

Date Filed

February 19, 2016

Patent primary examiner

‌

Kristin Vajda

Find more entities like US Patent 9580423 Bicyclic heterocycles as FGFR4 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API